Derrick Bennett

• Incidence of Transient Ischemic Attack in Auckland, New Zealand, in 2011 to 2012.

  Barber PA. et al, (2016), Stroke, 47, 2183 - 2188

• The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.

  Fiest KM. et al, (2016), Mult Scler

• Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults.

  Millwood IY. et al, (2016), J Am Coll Cardiol, 67, 230 - 231

• How to Distinguish between Statistically Significant Results and Clinically Relevant Results.

  Bennett DA., (2016), Front Neurol Neurosci, 39, 37 - 49

• Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  GBD 2013 Risk Factors Collaborators None. et al, (2015), Lancet, 386, 2287 - 2323

• Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

  Newton JN. et al, (2015), The Lancet, 386, 2257 - 2274

• Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.

  GBD 2013 DALYs and HALE Collaborators None. et al, (2015), Lancet, 386, 2145 - 2191

• Physical activity and the incidence of diabetes: evidence from the China Kadoorie Biobank study

  Bennett DA. et al, (2015), DIABETOLOGIA, 58, S154 - S154

• Development of the Standards of Reporting of Neurological Disorders (STROND) checklist: A guideline for the reporting of incidence and prevalence studies in neuroepidemiology.

  Bennett DA. et al, (2015), Neurology, 85, 821 - 828

• Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology.

  Bennett DA. et al, (2015), Eur J Epidemiol, 30, 569 - 576

• Reply to Garrard and Jacoby and Smith et al.

  Clarke R. et al, (2015), Am J Clin Nutr, 101, 416 - 417

• Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  GBD 2013 Mortality and Causes of Death Collaborators None., (2015), Lancet, 385, 117 - 171

• Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study.

  Feigin VL. et al, (2015), Neuroepidemiology, 45, 161 - 176

• Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013.

  Barker-Collo S. et al, (2015), Neuroepidemiology, 45, 203 - 214

• Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

  Vos T. et al, (2015), The Lancet, 386, 743 - 800

• Explanation and Elaboration of the Standards of Reporting of Neurological Disorders Checklist: A Guideline for the Reporting of Incidence and Prevalence Studies in Neuroepidemiology.

  Bennett DA. et al, (2015), Neuroepidemiology, 45, 113 - 137

• A Commentary on the Standards of Reporting of Neurological Disorders Checklist: A Guideline for the Reporting of Descriptive Studies in Neuroepidemiology.

  Bennett DA. et al, (2015), Neuroepidemiology, 45, 71 - 72

• 30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand (1981-2012): A Multi-Ethnic Population-Based Series of Studies.

  Feigin VL. et al, (2015), PLoS One, 10

• Global burden of stroke - An update

  Feigin V. et al, (2014), INTERNATIONAL JOURNAL OF STROKE, 9, 5 - 5

• Commentary: Mendelian randomization study of tobacco smoking and cardiovascular risk factors: hazards of tobacco smoking greatly outweigh any benefits.

  Clarke R. and Bennett DA., (2014), Int J Epidemiol, 43, 1471 - 1472

• Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  Ng M. et al, (2014), Lancet, 384, 766 - 781

• Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.

  Feigin VL. et al, (2014), Stroke, 45, 1639 - 1645

• The global burden of ischemic stroke: findings of the GBD 2010 study.

  Bennett DA. et al, (2014), Glob Heart, 9, 107 - 112

• The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study.

  Krishnamurthi RV. et al, (2014), Glob Heart, 9, 101 - 106

• Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.

  Feigin VL. et al, (2014), Lancet, 383, 245 - 254

• Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.

  Krishnamurthi RV. et al, (2013), Lancet Glob Health, 1, e259 - e281

• Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010

  Krishnamurthi RV. et al, (2013), LANCET GLOBAL HEALTH, 1, E259 - E281

• Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.

  Clarke R. et al, (2012), PLoS Med, 9

• Study protocol: systematic review of the burden of heart failure in low- and middle-income countries

  Bennett DA. et al, (2012), Systematic Reviews, 1

• Methodology of the global and regional burden of stroke study.

  Global Burden of Disease Stroke Expert Group None. and Bennett DA., (2012), Neuroepidemiology, 38, 30 - 40

• Text messaging in smoking cessation: the txt2stop trial.

  Bennett DA. and Emberson JR., (2011), Lancet, 378, 6 - 7

• C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study

  Emberson J. et al, (2011), Lancet, 377, 469 - 476

• Study protocol: the empirical investigation of methods to correct for measurement error in biobanks with dietary assessment.

  Bennett DA. et al, (2011), BMC Med Res Methodol, 11

• An introduction to instrumental variables analysis: part 1.

  Bennett DA., (2010), Neuroepidemiology, 35, 237 - 240

• An introduction to instrumental variables--part 2: Mendelian randomisation.

  Bennett DA., (2010), Neuroepidemiology, 35, 307 - 310

• Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

  Clarke R. et al, (2009), N Engl J Med, 361, 2518 - 2528

• Stratification for exploring heterogeneity in systematic reviews.

  Bennett DA. and Emberson JR., (2009), Evid Based Med, 14, 162 - 164

• Biostatistics for non-biostatisticians

  Bennett DA., (2009), Neuroepidemiology, 33, 315 - 316

• ACP Journal Club. Stratification for exploring heterogeneity in systematic reviews.

  Bennett DA. and Emberson JR., (2009), Ann Intern Med, 151, JC4 - JC3

• Common variants at 30 loci contribute to polygenic dyslipidemia

  Kathiresan S. et al, (2009), Nature Genetics, 41, 56 - 65

• Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.

  Elliott P. et al, (2009), JAMA, 302, 37 - 48

• Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.

  Feigin VL. et al, (2009), Lancet Neurol, 8, 355 - 369

• B vitamins for prevention of cognitive decline: insufficient evidence to justify treatment.

  Clarke RJ. and Bennett DA., (2008), JAMA, 300, 1819 - 1821

• Falls after stroke: results from the Auckland Regional Community Stroke (ARCOS) Study, 2002 to 2003.

  Kerse N. et al, (2008), Stroke, 39, 1890 - 1893

• The exon 1-8C/G SNP in the PSMA6 gene contributes only a small amount to the burden of myocardial infarction in 6946 cases and 2720 controls from a United Kingdom population

  Bennett DA. et al, (2008), Eur.J.Hum.Genet., 16, 480 - 486

• Empirical assessment of the validity of the 'fundamental theorem of the HapMap' in the light of 'cryptic' tagging of multiple susceptibility loci.

  Bochdanovits Z. et al, (2008), Eur J Hum Genet, 16, 525 - 529

• Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

  Willer CJ. et al, (2008), Nat Genet, 40, 161 - 169

• Chitosan for overweight or obesity.

  Jull AB. et al, (2008), Cochrane Database Syst Rev

• Handbook of clinical neuroepidemiology

  Feigin VL. and Bennett DA., (2007), Handbook of Clinical Neuroepidemiology, 1 - 690

• Fundamental statistical and epidemiological concepts

  Bennett DA. and Feigin VL., (2007), 3 - 64

• Cerebrovascular disorders

  Feigin VL. et al, (2007), 67 - 103

• Corticosteroids in patients with hemorrhagic stroke

  Feigin VL. et al, (2006), Stroke, 37, 1344 - 1345

• Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both?

  Emberson JR. and Bennett DA., (2006), Vasc Health Risk Manag, 2, 239 - 249

• Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies.

  Feigin VL. et al, (2005), Stroke, 36, 2773 - 2780

• Risk of disability due to car crashes: a review of the literature and methodological issues.

  Ameratunga SN. et al, (2004), Injury, 35, 1116 - 1127

• A phenome-wide association study of a lipoproteinassociated phospholipase A2 loss-of-function variant in 90 000 Chinese adults

  Millwood IY., International Journal of Epidemiology

Recent Publications

• Incidence of Transient Ischemic Attack in Auckland, New Zealand, in 2011 to 2012.

  Barber PA. et al, (2016), Stroke, 47, 2183 - 2188

• The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.

  Fiest KM. et al, (2016), Mult Scler

• Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults.

  Millwood IY. et al, (2016), J Am Coll Cardiol, 67, 230 - 231

• How to Distinguish between Statistically Significant Results and Clinically Relevant Results.

  Bennett DA., (2016), Front Neurol Neurosci, 39, 37 - 49

• Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  GBD 2013 Risk Factors Collaborators None. et al, (2015), Lancet, 386, 2287 - 2323